| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.023 | 0.7 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
| mRNA | AMG-706 | FIMM | pan-cancer | AAC | -0.095 | 0.7 |
| mRNA | Doxorubicin | FIMM | pan-cancer | AAC | -0.084 | 0.7 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.09 | 0.7 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.097 | 0.7 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.7 |